IQ Hedge Long/Short Tracker ETF (QLS) is an exchange-traded fund that provides investors with exposure to a diversified portfolio of long/short equity hedge fund strategies through a passive tracking approach. The ETF seeks to replicate the performance of the IQ Hedge Long/Short Index, which invests in a selection of publicly traded hedge fund clones, commodity trading advisors, and multi-strategy managers; it employs both long positions in equities expected to outperform and short positions in those anticipated to underperform, aiming for market-neutral returns with reduced volatility. QLS offers daily liquidity, low expense ratios typical of index-tracking ETFs, and transparency via its underlying index methodology, targeting institutional and retail investors seeking alternative investment exposure without direct hedge fund access.
Operated within the asset management industry, specifically the alternative investments segment, QLS focuses on U.S. equities and derivatives markets as its primary target. Geographically, it operates globally through U.S.-listed exchange trading, with assets under management accessible to investors worldwide via major brokerage platforms. Launched in 2015 by IndexIQ Advisors LLC, a subsidiary of New York Life Investments, the ETF is headquartered in Rye Brook, New York.
In recent developments, QLS underwent a strategic rebranding and ticker symbol change in early 2025 as part of IndexIQ's portfolio optimization efforts amid rising demand for hedge-like strategies in volatile markets; this followed a significant assets under management increase of over 25% in 2024 driven by inflows from retirement plans and RIAs. Additionally, IndexIQ announced a partnership with Bluefin Trading in late 2024 to enhance execution efficiency for its short positions, reducing tracking error; no major acquisitions or funding rounds were reported, but the ETF expanded its index constituents to include more AI-themed long/short managers in response to sector growth. These changes position QLS for sustained growth in the $100 billion-plus hedge fund replication market.